AS
Ankur Srivastav
About Ankur Srivastav
Data last updated:
Ankur Srivastav is a Director at Krupitha Life Sciences Private Limited (since 2024) and Director at Geetank Pharmaceutical Private Limited (since 2021). The companies operate in Automotive and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹33.1 Lakh; the largest is Krupitha Life Sciences Private Limited at ₹18.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Krupitha Life Sciences Private Limited U73200UP2022PTC158809 | Director | 19 Jun 2024 | 2022 | ₹18.2 Lakh (FY 2025) | Active |
 Geetank Pharmaceutical Private Limited U74999UP2021PTC148012 | Director | 30 Jun 2021 | 2021 | ₹14.9 Lakh (FY 2025) | Active |
Board colleagues of Ankur Srivastav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vikas Mishra | 09662595 | Krupitha Life Sciences Private Limited | Director |
| Yogesh Mishra | 11519505 | Krupitha Life Sciences Private Limited | Director |
| Geeta Srivastava | 09221732 | Geetank Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankur Srivastav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankur Srivastav
Ankur Srivastav currently holds 2 directorships: Krupitha Life Sciences Private Limited (Director, since 19 Jun 2024, revenue ₹18.2 Lakh (FY 2025)); Geetank Pharmaceutical Private Limited (Director, since 30 Jun 2021, revenue ₹14.9 Lakh (FY 2025)).
Ankur Srivastav was first appointed on 30 Jun 2021 as Director at Geetank Pharmaceutical Private Limited. The most recent appointment on record is 19 Jun 2024 at Krupitha Life Sciences Private Limited.
The 2 current companies of Ankur Srivastav that report revenue have a combined latest revenue of ₹33.1 Lakh: Krupitha Life Sciences Private Limited ₹18.2 Lakh (FY 2025); Geetank Pharmaceutical Private Limited ₹14.9 Lakh (FY 2025).
The current boards of Ankur Srivastav's companies include Vikas Mishra (Krupitha Life Sciences Private Limited), Yogesh Mishra (Krupitha Life Sciences Private Limited), Geeta Srivastava (Geetank Pharmaceutical Private Limited).